DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ rose 1.40% to $18.78 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 0.09% to 19,286.78 and the Dow Jones Industrial Average rising 0.59% to 43,988.99.
The stock's rise snapped a two-day losing streak.
Corbus Pharmaceuticals Holdings Inc. closed $43.12 below its 52-week high ($61.90), which the company reached on July 31st.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 3.39% to $5.19, Fortress Biotech Inc. (FBIO) fell 0.58% to $1.71, and Viking Therapeutics Inc. $(VKTX)$ fell 0.54% to $68.48.
Trading volume (266,008) remained 500,723 below its 50-day average volume of 766,731.
Data source: Dow Jones Market Data, FactSet. Data compiled November 8, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
November 08, 2024 17:24 ET (22:24 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments